TARGETED TECHNOLOGY FUND
The Targeted Technology Fund II, like Fund I, is focused on early stage investments in companies that they believe can advance ground breaking or disruptive technologies to significantly improve the practice of medicine and patient outcomes. They also favor technologies that can positively improve the efficiency, cost, or functionality of the development and manufacture of life science products.
TARGETED TECHNOLOGY FUND
Founded:
2009-01-01
Status:
Active
Contact:
(210)558-8896
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Mobile Non Scaleable Content Adobe Dreamweaver WordPress 3.8
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-11-21 | Cardiovate | Targeted Technology Fund investment in Seed Round - Cardiovate | 1000 K USD |
| 2017-06-06 | neoSurgical | Targeted Technology Fund investment in Series B - neoSurgical | 5.5 M USD |
| 2016-03-22 | Aerin Medical | Targeted Technology Fund investment in Series C - Aerin Medical | 16.7 M USD |
| 2016-02-01 | Roxy’s Remedies | Targeted Technology Fund investment in Series A - Roxy’s Remedies | N/A |
| 2015-04-14 | StemBioSys | Targeted Technology Fund investment in Series A - StemBioSys | 8 M USD |
| 2015-01-27 | Xenex | Targeted Technology Fund investment in Venture Round - Xenex | 25 M USD |
| 2014-10-14 | DNAtriX | Targeted Technology Fund investment in Series B - DNAtriX | 20 M USD |
| 2014-07-30 | Bluegrass Vascular Technologies | Targeted Technology Fund investment in Series A - Bluegrass Vascular Technologies | 4.5 M USD |
| 2013-11-21 | Xenex | Targeted Technology Fund investment in Venture Round - Xenex | 11.3 M USD |
| 2013-04-18 | ViroXis | Targeted Technology Fund investment in Series A - ViroXis | 7.79 M USD |